Results 21 to 30 of about 865,582 (335)

Pathological Role of Angiotensin II in Severe COVID-19

open access: yesTH Open, 2020
The activated renin–angiotensin system induces a prothrombotic state resulting from the imbalance between coagulation and fibrinolysis. Angiotensin II is the central effector molecule of the activated renin–angiotensin system and is degraded by the ...
Wolfgang Miesbach
doaj   +1 more source

Non-employment and low educational level as risk factors for inequitable treatment and mortality in heart failure: a population-based cohort study of register data

open access: yesBMC Public Health, 2021
Background The risk of heart failure is disproportionately high among the socioeconomically disadvantaged. Furthermore, socioeconomically deprived patients are at risk of inequitable access to heart failure treatment and poor outcomes.
Anna Ohlsson   +4 more
doaj   +1 more source

A Systems-Theoretical Formalization of Closed Systems [PDF]

open access: yesarXiv, 2023
There is a lack of formalism for some key foundational concepts in systems engineering. One of the most recently acknowledged deficits is the inadequacy of systems engineering practices for engineering intelligent systems. In our previous works, we proposed that closed systems precepts could be used to accomplish a required paradigm shift for the ...
arxiv  

Additional file 1: of Prenatal dexamethasone and postnatal high-fat diet have a synergistic effect of elevating blood pressure through a distinct programming mechanism of systemic and adipose reninâ angiotensin systems

open access: yes, 2018
Table S1. The primer sequences used for quantitative polymerase chain reaction (qPCR). (DOC 43Â kb)
Hong-Ren Yu   +10 more
openaire   +1 more source

Emerging pharmacological treatments to prevent abdominal aortic aneurysm growth and rupture [PDF]

open access: yes, 2015
Abdominal aortic aneurysm (AAA) is a local expansion of the abdominal aorta wall caused by a complex multifactorial maladaptive vascular remodeling. Despite recent advances in the management of cardiovascular diseases, there currently is no established ...
Fraga-Silva, Rodrigo   +2 more
core   +2 more sources

Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors [PDF]

open access: yes, 2016
Elevated serum aldosterone can be vasculotoxic and facilitate cardiorenal damage. Renin-angiotensin system inhibitors reduce serum aldosterone levels and/or block its effects but can cause hyperkalemia.
Bakris, George L.   +8 more
core   +1 more source

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

open access: yesCardiac Failure Review, 2019
Renin–angiotensin–aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF).
Giuseppe MC Rosano   +3 more
doaj   +1 more source

Effect of amaranth proteins on the RAS system: In vitro, in vivo and ex vivo assays [PDF]

open access: yes, 2020
The aim of this work was to analyse the hypotensive effect of amaranthprotein/peptides on spontaneously hypertensive rats (SHR). The mechanism of action of these peptides was studied in vivo and ex vivo.
Aphalo, Paula   +4 more
core   +2 more sources

THE INFLUENCE OF TISSUE ANGIOTENSINS ON ELEMENTS OF THE CARDIOVASCULAR SYSTEM (LECTURE)

open access: yesБайкальский медицинский журнал
Relevance. The renin-angiotensin system is today one of the oldest and most studied peptide cascades. Understanding the operation of this system is an urgent task for study in medical higher education institutions.
Liudmila O Gutsol, Irina E Egorova
doaj   +1 more source

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice [PDF]

open access: yes, 2003
Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension.
Aubert   +39 more
core   +5 more sources

Home - About - Disclaimer - Privacy